NKp44/NCR2 Antikörper (AA 201-276) (FITC)
Kurzübersicht für NKp44/NCR2 Antikörper (AA 201-276) (FITC) (ABIN740017)
Target
Alle NKp44/NCR2 (NCR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-276
-
Verwendungszweck
- NCR2 Polyclonal Antibody, FITC Conjugated
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CD336/NCR2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- NKp44/NCR2 (NCR2) (Natural Cytotoxicity Triggering Receptor 2 (NCR2))
-
Andere Bezeichnung
- Ncr2
-
Hintergrund
-
Synonyms: LY95, CD336, NKP44, NK-p44, dJ149M18.1, Natural cytotoxicity triggering receptor 2, Lymphocyte antigen 95 homolog, NK cell-activating receptor, Natural killer cell p44-related protein, NCR2
Background: Cytotoxicity-activating receptor that may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis.
-
Gen-ID
- 9436
-
UniProt
- O95944
Target
-